Dr. Karin Jorga, PhD, has over 20 years of experience in drug development of small and large molecules across all therapeutic areas. The focus of her international experience has been on transitioning pre-clinical lead molecules to Clinical Proof-of-Concept and advancing novel biomarkers to drive Personalized Healthcare. She has a substantial scientific track record in Clinical Pharmacology and a unique set of expertise that includes the usage of Biomarkers and application of Computer Models to overcome drug development hurdles and drive scientifically sound decision making.

Dr. Jorga’s past experience includes being the Global Head of Biomarker Technology and Science, Global Head of Clinical Pharmacology, and Global Head of Modeling and Simulation at Roche.

She currently runs a consulting firm, KarinJorga Life Science Consulting, that was founded in 2014 in Basel with the ambition to develop scientific innovations into medicines for tomorrow.